share_log

HC Wainwright & Co. Reiterates Buy on ITeos Therapeutics, Maintains $44 Price Target

Benzinga ·  Mar 7 07:27

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates ITeos Therapeutics (NASDAQ:ITOS) with a Buy and maintains $44 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment